EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseÜbersichtsarbeit

Efficacy and safety of automated insulin delivery system in very young children with type 1 diabetes: A systematic review and meta‐analysis of randomized controlled trials

Qiongyan Lin iD, Yongwen Zhou, Mengyun Lei, Ping Ling, Ying Ni, Ziqing Lin, Daizhi Yang, Wen Xu, Hongrong Deng, Jinhua Yan iD

Diabetic Medicine · 2026

DOI: 10.1111/dme.70354 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Diabetic Medicine, 2026. Verfasst von Qiongyan Lin und 9 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Provincial Key Laboratory of Diabetology, Department of Endocrinology and Metabolism, The Third Affiliated Hospital of Sun Yat-sen Universi…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Insulin, Insulin Infusion Systems, Hypoglycemic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: Noncommunicable Chronic Diseases-National Science and Technology Major Project, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

To evaluate the efficacy and safety of automated insulin delivery (AID) systems in very young children with type 1 diabetes (T1D).

Methods

PubMed, Embase, Scopus, and Web of Science were searched until 10 October 2025. Inclusion criteria were randomized controlled trials (RCTs); T1D populations under 7 years old; comparing AID systems with standard care (SC). Primary efficacy endpoint was the percentage of time‐in‐range of 70–180 mg/dL (TIR) derived from continuous glucose monitoring (CGM), secondary outcomes included glycated haemoglobin (HbA1c), other CGM metrics, and insulin dose. Safety endpoints included severe hypoglycaemia (SH) and diabetic ketoacidosis (DKA).

Results

Four RCTs involving 292 participants were included. The mean age was 4.70 years, with a mean T1D duration of 1.96 years. The study duration ranged from 8 to 16 weeks. Compared with SC, AID significantly improved TIR by mean difference (MD) +9.29% (95% confidence interval [CI]: 7.27–11.30, I 2 = 70%, p < 0.001) accompanied by a favourable effect on HbA1c by MD −4 mmol/mol (−0.39%) (95% CI [−6 to −2] (−0.57 to −0.21), I 2 = 82%, p < 0.001). A favourable decrease in time‐above‐range (TAR, >180 mg/dL; >250 mg/dL) and mean blood glucose were also observed in AID over SC (all p < 0.05). No significant differences were observed between AID and SC groups in time in hypoglycaemia, insulin dose, and risk of SH and DKA (all p > 0.05).

Conclusion

AID systems may outperform SC in improving short‐term glycaemic control (TIR, HbA1c, TAR) in very young children with T1D, without increasing time in hypoglycaemia, insulin dose, or risk of SH and DKA. These preliminary findings support the clinical potential of AID systems and highlight the need for longer term studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 1InsulinInsulin Infusion SystemsHypoglycemic AgentsHumansRandomized Controlled Trials as TopicChild, PreschoolContinuous Glucose MonitoringChildHypoglycemiaGlycated HemoglobinBlood GlucoseIntelligent SystemsTreatment Outcome

Stichwörter der Autor:innen

insulin infusion systemsmeta‐analysispreschool childsystematic reviewtype 1 diabetes mellitus

Substanzen

InsulinHypoglycemic AgentsGlycated HemoglobinBlood Glucose

Autor:innen und Institutionen

  • Guangdong Provincial Key Laboratory of Diabetology, Department of Endocrinology and Metabolism, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
  • Department of Endocrinology, Zhongnan Hospital of Wuhan University, Wuhan, China.
  • Departmemnts of Nephrology, Guangdong Academy of Medical Science, Guangdong Provincial People's Hospital, Southern Medical University, Guangzhou, China.

ORCID-Profile: Qiongyan Lin, Jinhua Yan

Förderung

  • Noncommunicable Chronic Diseases-National Science and Technology Major Project
  • National Natural Science Foundation of China

Zitieren

APA

Lin, Q., Zhou, Y., Lei, M., Ling, P., Ni, Y., Lin, Z., Yang, D., Xu, W., Deng, H., & Yan, J. (2026). Efficacy and safety of automated insulin delivery system in very young children with type 1 diabetes: A systematic review and meta‐analysis of randomized controlled trials. Diabetic Medicine. https://doi.org/10.1111/dme.70354

Vancouver

Lin Q, Zhou Y, Lei M, Ling P, Ni Y, Lin Z, et al. Efficacy and safety of automated insulin delivery system in very young children with type 1 diabetes: A systematic review and meta‐analysis of randomized controlled trials. Diabetic Medicine. 2026. doi:10.1111/dme.70354

BibTeX
@article{Lin2026,
  author = {Lin, Qiongyan and Zhou, Yongwen and Lei, Mengyun and Ling, Ping and Ni, Ying and Lin, Ziqing and Yang, Daizhi and Xu, Wen and Deng, Hongrong and Yan, Jinhua},
  title = {Efficacy and safety of automated insulin delivery system in very young children with type 1 diabetes: A systematic review and meta‐analysis of randomized controlled trials},
  journal = {Diabetic Medicine},
  year = {2026},
  doi = {10.1111/dme.70354}
}
Kostenlos starten →